Review of the article “Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients”

IF 0.1 Q4 ONCOLOGY

Onkourologiya Pub Date : 2021-02-10 DOI:10.17650/1726-9776-2020-16-4-48

A. Vinarov

引用次数: 0

Abstract

查看原文本刊更多论文

“肾细胞癌患者血浆肾损伤分子(KIM-1)的临床意义”一文综述

．

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Onkourologiya ONCOLOGY-

CiteScore

0.40

自引率

0.00%

发文量

审稿时长

10 weeks

期刊介绍： The main objective of the journal "Cancer urology" is publishing up-to-date information about scientific clinical researches, diagnostics, treatment of oncologic urological diseases. The aim of the edition is to inform the experts on oncologic urology about achievements in this area, to build understanding of the necessary integrated interdisciplinary approach in therapy, alongside with urologists, combining efforts of doctors of various specialties (cardiologists, pediatricians, chemotherapeutists et al.), to contribute to raising the effectiveness of oncologic patients’ treatment.